Clinical Trial Results:
A randomized, double-blind, placebo controlled, multi-centre, phase IIA study to assess the effect on GERD symptoms, pharmacokinetics, safety and tolerability of four weeks treatment with AZD3355 65 mg bid as add-on treatment to a PPI in patients with an incomplete response to PPI treatment
Summary
|
|
EudraCT number |
2006-003541-16 |
Trial protocol |
FR NO NL DE HU BE |
Global completion date |
01 Jun 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Aug 2016
|
First version publication date |
12 Aug 2016
|
Other versions |
|
Summary report(s) |
D9120C00011/GI |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.